Bragar Eagel & Squire, P.C. Reminds Investors that it is Investigating the Boards of Directors of Clementia, Multi-Color, and GTx on Behalf of Stockholders and Encourages Investors to Contact the Firm
March 20, 2019 21:00 ET
|
Bragar Eagel & Squire
NEW YORK, March 20, 2019 (GLOBE NEWSWIRE) -- Bragar Eagel & Squire, P.C. reminds investors that it is investigating potential claims on behalf of stockholders of Clementia Pharmaceuticals Inc.,...
Bragar Eagel & Squire, P.C. is Investigating the Board of Directors of Clementia Pharmaceuticals Inc. (CMTA) on Behalf of Stockholders and Encourages CMTA Investors to Contact the Firm
February 25, 2019 20:23 ET
|
Bragar Eagel & Squire
NEW YORK, Feb. 25, 2019 (GLOBE NEWSWIRE) -- Bragar Eagel & Squire, P.C. is investigating potential claims against the board of directors of Clementia Pharmaceuticals Inc. (NASDAQ: CMTA) on...